期刊文献+

IL-35在心血管疾病中的研究进展

Research progress of IL-35 in cardiovascular diseases
下载PDF
导出
摘要 心血管疾病是当前威胁全民健康的一类常见病,也是主要致死病因之一。细胞因子在心血管疾病发病过程中发挥重要作用。作为白细胞介素(interleukin,IL)-12家族的一员,白细胞介素35(interleukin 35,IL-35)是一种主要由调节性T细胞分泌的、具有免疫抑制功能的细胞因子。近期研究表明,IL-35也参与心血管疾病的发生、发展。本文综述了IL-35的结构、信号通路与功能,总结了IL-35在心血管疾病发病中的调控作用与机制的相关研究进展,旨在为心血管疾病预防和治疗提供新的思路和方向。 Cardiovascular disease is a common disease that threatens the health of human and is also one of the main causes of death.Cytokines play an important role in the pathogenesis of cardiovascular diseases.As a member of the interleukin-12(IL-12)family,IL-35 is an inhibitory cytokine produced mainly by regulatory T cells.Recent studies have shown that IL-35 is involved in the development of cardiovascular diseases.This paper reviews the structure,signaling pathway and biological function of IL-35 and summarizes the research progress of the regulatory role and mechanism of IL-35 in the pathogenesis of cardiovascular diseases,aiming to provide new ideas and directions for the prevention and treatment of cardiovascular diseases.
作者 徐静 白蕴涵 陈淑珍 XU Jing;BAI Yun-han;CHEN Shu-zhen(Department of Pharmacy,Xiamen Medical College,Xiamen 361023,Fujian,China;Department of Pathogenic Biology and Immunology&Fujian Provincial Key Laboratory of Functional and Clinical Translational Medicine,Xiamen Medical College,Xiamen 361023,Fujian,China)
出处 《心脏杂志》 CAS 2023年第2期204-207,212,共5页 Chinese Heart Journal
基金 国家自然科学基金项目(31901008) 福建省卫生健康中青年骨干人才培养项目(2019-ZQNB-22) 厦门市青年创新基金项目(3502Z20206087) 福建省大学生创新创业训练计划项目(202012631012)。
关键词 IL-35 心血管疾病 动脉粥样硬化 免疫抑制 IL-35 cardiovascular disease atherosclerosis immunosuppression
  • 相关文献

参考文献2

二级参考文献30

  • 1世界卫生组织及国际心脏病学会工作组.成人急性病毒性心肌炎诊断参考标准.中国循环杂志,2001,8(14):307-307.
  • 2Ohshima M, Yamahara K, Ishikane S, et al. Systemic transplanta- tion of allogenic fetal membrane-derived mesenchymal stem ceils suppresses Thl and Thl7 T cell responses in experimental autoim- nmne myocarditis[ J]. J Mol Cell Cardiol, 2012,53 (3) :420-428.
  • 3Wang RX, Yu CR, Dambuza IM, et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease [ J]. Nat Med, 2014, 20(6) :633-641.
  • 4Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis [J]. J Am Coil Cardiol, 2012,59(9) :779-792.
  • 5Xie Y, Chen R, Zhang X, et al. The role of Thl7 cells and regu- latory T cells in Coxsackievirus B3-induced myocarditis[ J]. Viral- ogy, 2011,1421 ( 1 ) :78-84.
  • 6Sonderegger I, Rtihn TA, Kurrer MO, et al. Neutralization of IL- 17 by active vaccination inhibits IL-23-dependent autoimmune myo-carditis[ J]. Eur J Immunol, 2006,36 ( 11 ) :2849-2856.
  • 7Yuan J, Yu M, Lin QW, et al. Neutralization of IL-17 inhibits the production of anti-ANT autoantibodies in CVB3-induced acute viral myocarditis [J]. Int hnmunopharmacol, 2010,10 (3) :272-276.
  • 8Banchereau J, Pascual V, O'Garra A. From IL-2 to IL-37 : the ex- panding spectrum of anti-inflammatory cytokines [ J ]. Nat Immu- nol, 2012,13(10) :925-931.
  • 9Matsui Y, Inobe M, Okamoto H, et al. Blockade of T cell costim- ulatory signals using adenovirus vectors prevents both the induction and the progression of experimental autoimmune myocarditis[ J]. J Mol Cell Cardiol, 2012,34(3) :279-295.
  • 10Ye S, Wu J, Zhou L, et al. Interleukin-35 : the future of hyperim- mune-related diseases [J]. J Interferon Cytokine Res, 2013,33 (6) :285-291.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部